Medline Industries is under investigation by Pomerantz LLP for potential securities fraud following an FDA warning about significant manufacturing violations. The FDA highlighted Medline's failure to properly investigate discrepancies in pharmaceutical batches. This news caused Medline's stock to drop 7.16% on June 2, 2026. The investigation may lead to legal action for investors who suffered losses due to the company's alleged misconduct.
Emmy-winning actor and gamer Seth Green has joined the Global Gaming League's Advisory Board to help shape its future at the intersection of gaming and entertainment. To celebrate, GGL launched "Ready, Seth, Go!", a 10-event tournament series on its ...
The global digital advertising market is forecasted to grow from $567.9 billion in 2025 to $2.06 trillion by 2033, with a 17.6% CAGR. Growth is fueled not just by expansion but by a strategic reallocation of budgets toward digital platforms offering ...
NIRI Florida has announced its Board of Directors for the 2026-2027 term, with Charlotte Murnan appointed as President. The board includes professionals from various companies, focusing on growing membership and delivering valuable programming for in...
7th Avenue, a Los Angeles-based modern furniture brand, has opened its first showroom on Long Island at Walt Whitman Shops in Huntington Station, New York. This 1,206-square-foot experiential space allows customers to try and customize modular sofas ...
SK Hynix, a trillion-dollar South Korean chipmaker, will start trading on Nasdaq under the ticker SKHY on July 10, marking its first US listing. Following this, GraniteShares will launch two ETFs on July 13: a 2x long ETF (SKUU) and a 2x short ETF (S...
